This inventor holds 1 USPTO granted patent. Top assignee: Metagen Pharmaceuticals Gmbh. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Thomas Specht: Innovator in Nucleic Acid Research
Introduction
Thomas Specht is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of molecular biology, particularly in the study of human nucleic acid sequences. His work has implications for understanding endometrial tumors and their genetic underpinnings.
Latest Patents
Thomas Specht holds a patent for "Human nucleic acid sequences from endometrial tumor tissue." This patent describes human nucleic acid sequences, including mRNA, cDNA, and genomic sequences derived from endometrial tumor tissue. These sequences code for gene products or portions thereof, and their potential applications are also outlined. Additionally, the patent discusses the polypeptides that can be obtained from these sequences and their uses in research and medicine.
Career Highlights
Thomas Specht is associated with Metagen Pharmaceuticals GmbH, where he continues to advance his research in the field. His work is pivotal in exploring the genetic factors associated with endometrial tumors, contributing to the broader understanding of cancer biology.
Collaborations
Some of his notable coworkers include Armin Schmitt and Christian Pilarsky. Their collaborative efforts enhance the research output and innovation at Metagen Pharmaceuticals GmbH.
Conclusion
Thomas Specht's contributions to the field of nucleic acid research are significant, particularly in the context of endometrial tumors. His patent and ongoing work at Metagen Pharmaceuticals GmbH highlight his role as an innovator in this critical area of study.